Why is premixed insulin the preferred insulin? novel answers to a decade-old question

Journal of Association of Physicians of India

Volumn 61, Issue SPL. 1, 2013, Pages 9-11

  Kalra, S ^a   Balhara, Y P S ^b   Sahay, B K ^c   Ganapathy, B ^d   Das, A K ^e  

^a Bharti Hospital and BRIDE ^*  (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

^c OSMANIA MEDICAL COLLEGE   (India)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; ASIAN; CAUCASIAN; CLASSIFICATION; CLINICAL PRACTICE; ETHNOLOGY; HUMAN; INDIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PSYCHOLOGICAL ASPECT;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; INSULIN; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS;

EID: 84875173362     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Diabetologia 2012 Apr 20. [Epub ahead of print]
2. Rodbard HW, Jellinger PS. The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm. Diabetologia 2010;53:2458-60.
3. Treatment Algorithm for People with Type 2 Diabetes. Available at http://www.idf.org/treatment-algorithm-people-type-2-diabetes. [Accessed on 01 May 2012].
4. Indian National Consensus Group. Premix Insulin: Initiation and Continuation Guidelines for Management of Diabetes in Primary Care. J Assoc Physicians India 2009;57:S42-6.
5. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004;164:2090-95.
6. Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract 2007;77:280-5.
7. Guideline for Management of Postmeal Glucose in Diabetes 2011. Available at http://www.idf.org/2011-guideline-managementpostmeal-glucose-diabetes. [Accessed on 15 Dec 2011].
8. Home P, Naggar NE, Khamseh M, Gonzalez-Galvez G, Shen C, Chakkarwar P, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract 2011;94:352-63.
9. Raskin P, Allen E, Hollander P, Lewin A, Gabbay A, Hu P, et al. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28:260-65.
10. Christiansen JS, Vaz JA, Metelko, Bogoev M, Dedov I. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes. Diabetes Obes Metab 2003;5:446-54.
11. Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia 2009;52:1990-2000.
12. Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, et al. Risk for nocturnal hypoglycaemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis. Clin Ther 2009;31:1641-51.
13. Valensi J, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix_30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVETM observational study. Int J Clin Pract 2009;63:522-31.
14. Strojek K, Bebakar WM, Khutsoane DT, Pesic M, Smahelová A, Thomsen HF, et al. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. Curr Med Res Opin 2009;25:2887-94.
15. Kalra S, Plata-Que T, Kumar D, Mumtaz M, Søndergaard F, Kozlovski P, et al. Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs. Diabetes Res Clin Pract 2010;88:282-8.
16. John M, Kalra S, Unnikrishnan AG, Ganapathy B, Baruah MP, Sahay RK. Recommendations for insulin initiation based on ethnicity. Medical Hypotheses 2011;77:460-61.
17. John M, Kalra S. Ethnopharmacy In: Bajaj S, ed. ESI. Manual of Clinical Endocrinology Hyderabad: Endocrine Society of India, 2012.
18. Venn BJ, Williams SM, Mann JI. Comparison of postprandial glycaemia in Asians and Caucasians. Diabet Med 2010;27:1205-08.
19. Sahay BK, Fifty years of insulin and diabetes: A senior physician's experience. Accepted in Indian J Endocrinol Metab.